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1. Introduction   
In the United States, periodic colorectal cancer (CRC) screening rates increased from 45% of 
the eligible population in 2002 to 63% in 2008 (Richardson et al., 2010). Over a similar time 
period, colonoscopy has become the most widely utilized colorectal cancer screening tool in 
the United States. In other countries, colonoscopy is the most commonly recommended 
screening test, particularly in Europe. However, in many locales in which other screening 
tests such as fecal occult blood tests (FOBT) are preferred due to cost or availability, 
colonoscopy is used to follow up on patients screening positive (Brenner et al., 2001; Hoff & 
Dominitz, 2010; Classen & Lambert, 2008). 
The ascendance of colonoscopy in the US corresponds with a significant reduction in 
colorectal cancer incidence and mortality. In the Annual Report to the Nation on the Status 
of Cancer from 1975-2006, microsimulation modeling demonstrated the relatively large 
contributions of screening, along with risk factor modifications and improved cancer 
treatments, to this decline (Edwards et al., 2010).  
The focus of this chapter is the effectiveness of colonoscopy, as a means to decrease CRC 
incidence and mortality. In addition, we identify factors including tumor biology, 
instrumental, patient-related issues and endoscopist characteristics that may influence the 
impact of colonoscopy on these rates.  
2. Randomized controlled trials in CRC screening using endoscopy  
Currently, there are no published randomized controlled trials examining the impact of 
colonoscopy on CRC incidence and mortality. Before we review the published studies 
involving the colonoscopy, we will first examine two randomized, controlled trials of 
sufficient size and duration using screening flexible sigmoidoscopy to address the same 
questions. The results of these studies are often extrapolated to support the efficacy of 
colonoscopy, which is often thought to be an extended sigmoidoscopy. In the first study, 
Atkin and colleagues randomized more than 170,000 people in 14 United Kingdom medical 
centers to either once-only flexible sigmoidoscopy or no screening, with 71% included in the 
exam arm. The median follow-up was 11.2 years. The incidence and mortality of colorectal 
cancer were measured in both intention-to-treat and per-protocol analyses. Overall CRC 
incidence reduction was 23%-33%. Overall CRC mortality reduction was 31%-43% and distal 
CRC mortality reduction was 50% (Atkin et al., 2010). The protective effect appears 
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persistent, with reduction of left-sided CRC incidence continuing at the rate of 0.02% to 
0.04% per year after year 5.  
In the second study with similar design, Hoff and colleagues in the NORCAP trial 
randomized more than 55,000 men and women between 55 to 64 years of age in Norway to 
once-only screening flexible sigmoidoscopy or no screening. The planned duration of 
follow-up was 15 years. The published study reported cumulative incidence after 7 years of 
follow-up. Interestingly, by intention-to-treat analysis, there was an insignificant (P= 0.16) 
reduction in overall CRC mortality by 27% and in rectosigmoid cancer mortality by 37%. 
Per-protocol analysis with its inherent risk of selection bias yielded a significant 59% 
reduction in overall CRC incidence and a significant 76% reduction in distal CRC incidence. 
The authors suggested that these findings might be the results of a short timeframe for the 
follow-up period (Hoff et al., 2009).  
Two other randomized controlled trials using screening flexible sigmoidoscopy, namely, the 
SCORE trial in Italy and the PLCO trial (US National Cancer Institute-led Prostate, Lung, 
Colorectal and Ovarian cancer screening trial) are expected to report on their results within 
the next few years (Segnan et al., 2002; PLCO NCI web page).  
In addition, researchers in Europe and the US are currently conducting a randomized 
controlled trial examining the efficacy of screening colonoscopy on CRC incidence and 
mortality. The Northern-European Initiative on Colorectal Cancer (NordICC) trial will 
randomly draw 66,000 individuals from population registries to compare screening 
colonoscopy with a control group of unscreened individuals for a planned follow-up period 
of 15 years. Final data collections and analyses are not expected until 2026 (Baxter & 
Rabeneck, 2010). 
3. CRC incidence and mortality after colonoscopy with adenomatous 
polypectomy 
Muto et al first proposed the adenoma-carcinoma sequence of colorectal cancer in 1975 (Muto 
et al., 1975). Endoscopic polypectomy interrupts the carcinogenic sequence by preventing the 
transformation of adenomas, thereby inhibiting cancer development. The seminal National 
Polyp Study (NPS) in 1993 provided primary evidence in support of this theory as well as the 
rationale for colonoscopy with polypectomy as the major method to prevent colorectal cancer 
(Winawer et al., 1993). In this study, 1418 patients were randomized post-adenoma removal to 
frequent (follow-up exams in years 1 and 3) and less frequent (exams in year 3) colonoscopies. 
Outcomes in each group were compared with three historical reference groups, two where 
polyps were simply observed and one general-population cohort (the Surveillance, 
Epidemiology, and End Results or SEER). After an average follow-up of 5.9 years, the 
interventional groups showed a 76% to 90% reduction in CRC incidence compared with the 
observed incidence in the reference groups (standardized incidence ratios (SIRs), 0.10, 0.12 and 
0.24, respectively). The cancer incidence rate was 0.6 cancers per 1000 person-years.  
Subsequent studies based on NPS demonstrated the persistent reduction in CRC mortality 
associated with the initial polypectomy. Zauber and colleagues used mathematical 
modeling to show that at 20 years, the cumulative mortality rate was 2.5% for patients who 
had an initial polypectomy, compared to 5.5% for patients who did not (Zauber et al., 2007). 
Colonoscopic polypectomy could reduce CRC deaths by about 90% among patients with 
adenomas and by about 50% in the general population. Furthermore, these significant 
reductions in CRC mortality were mainly associated with the index clearing colonoscopy, 
not with the subsequent surveillance examinations.  
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Similar strong reduction in CRC incidence was also reported in two other studies involving 
patients with adenoma removal. The Italian Multicentre Study Group, a retrospective, 
observational study of 1693 men and women who had polypectomy with a mean follow-up 
of 10.5 years, reported SIR of 0.34 and cancer incidence rate of 0.4 cancers per 1000 person-
years (Citarda et al., 2001). The Telemark Polyp Study, a prospective cohort study of 799 
men and women with a mean follow-up of 10 years, showed SIR of 0.2, and cancer incidence 
rate of 0.5 cancers per 1000 person-years, although the trend toward CRC mortality 
reduction was not significant (Thiis-Evensen et al., 1999).  
However, other studies examining the adenoma cohorts have demonstrated much less 
dramatic impact of colonoscopy with polypectomy. The Polyp Prevention Trial, the Wheat 
Bran Fiber Trial, the Funen Adenoma Follow-Up Trial, the Australian Polyp Study and the 
Combined Chemoprevention Trial have all shown cancer incidence rates 2 to 4 times higher 
than that of the NPS, actually approaching or exceeding the expected rate in the SEER data 
(1.7 cancers per 1000 person-years).  
The Polyp Prevention Trial was a randomized, double blind study of 2079 men and women 
with history of adenoma removal examining the effects of a low-fat, high-fiber diet on the 
adenoma incidence. Patients had surveillance colonoscopy at years 1 and 4 post-
randomization. The study found no benefits of nutritional intervention on incident 
adenomas. In addition, the cancer incidence rate was 2.2 cancers per 1000 person-years and 
more than 50% of prevalent cancers could be prevented or detected earlier if the quality of 
colonoscopy had been improved (Schatzkin et al., 2000; Pabby et al., 2005).  
The Wheat Bran Fiber Trial using a similar design studied the effects of high fiber on 
adenoma recurrence in 1429 men and women with adenomas. It found 41-48% recurrent 
adenomas located in the proximal colon and cancer incidence rate of 2.4 cancers per 1000 
person-years (Alberts et al., 2000).  
The Funen Adenoma Follow-Up Trial by Jorgensen et al randomized 1056 men and women 
with adenomas to surveillance colonoscopy at varying intervals between 6 and 48 months 
after the index colonoscopy with polypectomy. Its cancer incidence rate was 2.2 cancers per 
1000 person-years. It found a significant six-fold reduction in CRC incidence in the post-
polypectomy group if all carcinomas were assumed to develop from large (> or = 10 mm) 
adenomas or adenomas with severe dysplasia according to the adenoma-carcinoma 
sequence (Jorgensen et al., 1993). It also found a significant reduction in CRC mortality 
when compared with the normal population.  
The Australian Polyp Study by a single surgeon studied 645 patients with adenoma removal 
for a mean follow-up period of 4.4 years. The cancer incidence rate was 1.05 cancers per 1000 
person-years, which was at first glance indistinguishable from that of the general population. 
However, based on analysis of previously published data, the authors found that the risk of 
developing colorectal cancer in patients with adenomas was approximately 2.5 times higher 
than that of the general population (3.3 cancers per 1000 person-years). Therefore, the authors 
concluded that colonoscopy did reduce CRC incidence (Meagher & Stuart, 1994). 
The Combined Chemoprevention Trial consisted of 2915 patients drawn from three previous 
chemoprevention trials using calcium, aspirin and antioxidant vitamins in an effort to reduce 
polyp recurrence. It involved a large number of endoscopists from across North America, in 
both university and private practices. Its cancer incidence rate was 1.74 cancers per 1000 
person-years, with 84% in the early stage and approximately half found in the proximal colon 
(Robertson et al., 2005). The lowered cancer incidence rate, compared with the other studies, 
was partially attributed to the chemopreventive properties of aspirin and calcium. 
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4. Why these differences? 
Although all of these studies include participants who had an adenoma removed, 
methodological differences make comparisons of results difficult. First, criteria for patient 
enrollment differed in these studies. For instance, the NPS patients underwent rigorous 
baseline colonoscopic clearance of adenomas, with some (13%) receiving at least 2 
examinations, before randomization. The NPS also excluded patients with polyps larger 
than 3 cm in size, or with prior history of adenomas, while other trials included patients 
with history of adenomas and any-sized polyps (Rex & Eid, 2008). Second, colonoscopic 
follow-up periods varied among the studies (Table 1). The NPS, Italian Multicentre Study 
and the Telemark Polyp Study had a mean follow-up of 6 to 13 years, whereas the others 
had much shorter follow-up periods, 3-4 years at most. As discussed below, cancers 
detected during the shorter follow-up periods were possibly due to lesions missed initially, 
not true incident cancers seen in longer follow-up (Robertson et al., 2007). Third, the 
expected cancer incidence rates in the various cohorts are difficult to measure due to 
differences in the type and size of adenomas removed at study entry (Kahi et al., 2009). 
Fourth, differences in the rate and the timing of the follow-up colonoscopy might also lead 
to variable outcomes. For example, one-fifth of the NPS and one-fourth of the Italian Trial 
subjects did not have follow-up colonoscopic surveillance, while most of the subjects in the 
chemoprevention trials did. Fifth, other confounding factors such as the use of 
chemopreventive agents such as aspirin, family history of CRC, cigarette smoking history 
were not fully accounted for and might not be comparable in these studies.  
 
Study 
Number 
of 
patients 
Cancer 
incidence 
rate (per 
1000 pr-yrs) 
Number of 
cancer in 
follow-up 
Mean 
follow-
up 
(years) 
SIR 
SEER  1.7    
NPS--Winawer 1993 1481 0.6 5 5.9 0.1-0.24 
Italian Polyp Study--
Citarda 2001 
1693 0.4 6 10.5 0.34 
Telemark Polyp 
Study--Thiis-Evensen 
1999 
799 0.5 1 10 0.2 
Polyp Prevention 
Study--Schatzkin 2000 
2079 2.2 13 3.1  
Wheat Bran Trial 
Alberts 2000 
1429 2.4 9 3.0  
Funen Adenoma 
Trial--Jorgensen 1993 
1056 2.2 10 4.3  
Combined 
Chemoprevention 
Trial--Robertson 2005 
2915 1.74 19 3.7  
Australian Polyp 
Study—Meagher 1994
645 1.05 3 4.4  
Table 1. Adenoma Cohorts and Interval Cancers 
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5. CRC incidence in screening cohorts      
Despite the significant, although variable, reduction in CRC incidence risk for patients with 
prior adenoma removal, these higher risk populations may not have direct applicability to 
screening settings where only a proportion of participants have adenomas.  
The incidence of CRC has been examined in a number of screening cohorts. Lieberman et al 
in 2000 studied 3121 individuals, 97% of who were men, for the Veterans Affairs 
Cooperative Study 380. They found that 37.5% of patients had neoplastic lesions. The 
presence of distal lesions increased the risk of proximal lesions (OR 3.4). However, 52% of 
proximal advanced neoplasms had no distal lesions (Lieberman et al., 2000). When 1193 
previously screened patients had a follow-up colonoscopy within 5.5 years, 22 cancers and 
high-grade dysplastic lesions (1.8%) were identified. Most of these lesions (15/22) were 
found within 36 months of the initial colonoscopy and 6 out of 9 cancers were located in the 
proximal colon (Lieberman et al., 2007).  
In 2005, Schoenfeld et al investigated the prevalence and location of advanced colonic 
neoplasia in women of average and high risk (15.7% had a family history of colon cancer). 
Among 1463 asymptomatic women who underwent screening colonoscopy, 72 had 
advanced neoplasia (4.9%). Had flexible sigmoidoscopy, which visualizes only the distal 
colon, been the screening tool, only 35.2% of women with advanced neoplasia would have 
been identified, compared to 66.3% of men from the VA Cooperative Study 380 (P<0.001) 
(Schoenfeld et al., 2005). The Schoenfeld study provided support for the concept that 
screening needs of women may differ from those of men. 
In a similar vein, the use of the screening colonoscopy in high-risk families was further 
advocated by the prospective, observational study with a long follow-up period of 16 years 
by Dove-Edwin et al. In this study, 1678 individuals from high-risk families with hereditary 
non-polyposis colorectal cancer (HNPCC) and moderate-risk families with up to 3 affected 
first-degree relatives had screening colonoscopy. Significant reduction of CRC incidence in 
these screening cohorts were 80% and 43% in the moderate-risk and high-risk groups, 
respectively, when compared to the expected incidence in similar families lacking 
surveillance (Dove-Edwin et al., 2005).  
Brenner and colleagues studied two different patient populations in Germany, one in the 
state of Saarland and the other in the Rhine-Neckar region, by two different methods to 
assess the question of CRC protection from previous screening colonoscopy. In the study 
from Saarland, the prevalence of advanced neoplasms including CRC in 586 participants 
following colonoscopy within the previous 10 years was compared to that in 2701 
participants with no previous colonoscopy. Adjusted prevalence ratios were 0.52 for overall 
CRC, 0.33 for combined left colon and rectum, and 1.05 for right-sided colon (cecum to 
transverse colon) (Brenner et al., 2010a). Thus, this study showed that in the community 
setting with experienced endoscopists (completing at least 200 colonoscopies and 50 
polypectomies), screening colonoscopy reduced the CRC incidence strongly in the distal, 
but not in the proximal, colon. 
In contrast, a second study by Brenner and colleagues suggested that colonoscopy protected 
against proximal CRC in average risk populations. This population-based, case-control 
study based in the Rhine-Neckar region of Germany, examined 1688 CRC cases and 1932 
controls and their history of previous colonoscopy within 1 to 10 years. The adjusted odds 
ratios were 0.23 for overall CRC, 0.16 for left-sided CRC and 0.44 for right-sided CRC. 
Significant risk reduction increased over the years in both right and left colon, in both sexes, 
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and among those with and without family history of CRC, with the exception of moderate, 
non-significant risk reduction for right-sided CRC in persons aged 50-59 years (Brenner et 
al., 2011). 
Two main factors are likely explanations for the different results in these two studies. The 
first report included participants with advanced adenomas and CRC, while the second 
included only CRC patients. The development of advanced adenomas may take less time 
that that of CRC. In addition, the 10-year cumulative risk of progressing from advanced 
adenoma to CRC is estimated to be less than 50% in individuals 55 years or older (Brenner et 
al., 2007). Second, the frequency of patients with right-sided CRC in the second study was 
much higher compared to the number of patients with right-sided advanced neoplasms in 
the first study, resulting in better statistics.    
6. CRC mortality associated with colonoscopy 
Prospectively demonstrating the beneficial effect of any intervention on CRC mortality is 
difficult given the disease’s relatively long latency, and methodological needs for many 
participants with long follow-up. Disease latency also contributes to a possible 
underestimate of CRC prevalence. In addition, prevalent and incident cancer rates are often 
indistinguishable in the reference groups such as SEER data. If colonoscopy reduces the 
incidence of CRC in different screening populations, then could we logically deduct that it 
has to reduce CRC mortality as well?   
In a population-based, observational cohort study, Kahi et al reported on 10,492 
asymptomatic average-risk patients with screening colonoscopy in a university hospital 
setting. Median post-colonoscopy follow-up was 8 years (range 3-16 years). Compared to 
expected rates from the SEER data, the SIR was 0.33 (a relative risk reduction of 67%). 
Likewise, the standardized mortality rate was 0.35 (a relative risk reduction of 65%) (Kahi et 
al, 2009).  
Another study by Singh et al used Manitoba’s billing claims database to follow, until 2008, a 
large cohort of 24,342 men and 30,461 women, who had their first colonoscopy between 1987 
and 2007. CRC mortality after the index colonoscopy was compared with that of the general 
population. Standardized mortality ratios (SMRs) were 0.71 (29% reduction) in overall 
mortality, 0.53 (47% reduction) in distal CRC mortality and 0.94 (no reduction) in proximal 
CRC mortality (Singh et al., 2010a).  
Baxter et al using a different administrative claims database from Ontario selected 719 case 
patients with a CRC diagnosis between 1996 and 2001, all of whom died of CRC by 2003. 
They were matched against 5031 controls. Colonoscopy was strongly associated with fewer 
deaths from left-sided CRC (adjusted OR 0.33 [95% CI, 0.28-0.39]), but not from right-sided 
CRC (adjusted OR 0.99 [95% CI, 0.86-1.14]) (Baxter et al., 2009). In this study, screening 
colonoscopy could not be differentiated from diagnostic procedures and completeness of 
exams could not be verified. 
Because of the methodological challenges associated with the studies of CRC mortality, 
other investigators have turned to mathematical models in an attempt to answer the same 
questions. As mentioned above, Edwards and colleagues have shown by micro-simulation 
modeling that declines in CRC mortality rates are consistent with a relatively large 
contribution from screening. These declines could be accelerated further with favorable 
trends in higher utilization of screening (Edwards et al., 2010). Similar findings were also 
found by other studies (Zauber et al., 2007; Vogelaar et al., 2006). Vogelaar et al also applied 
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a microsimulation model to the 2000 US population to study CRC risk factor prevalence, 
screening use and treatment use. They concluded that without many changes to the current 
trends (e.g., CRC screening in the eligible population rates are 43% and 47% in women and 
men, respectively), CRC mortality would be reduced by 17% by 2020. However, if screening 
use were increased to 70% of the target population, in tandem with improvement of CRC 
risk factors and chemotherapy effectiveness, then the reduction in CRC mortality could 
reach almost 50% by 2020. Screening and surveillance methods in this study included both 
sigmoidoscopy and colonoscopy with FOBT. 
7. CRC protection in patients after a negative colonoscopy 
A number of studies have demonstrated that CRC protection after a negative colonoscopy is 
durable, perhaps as long as 10-15 years. In two prospective cohort studies of average-risk 
subjects, Rex and Imperiale showed that no CRC was detected at re-screening 5 years after 
the negative baseline colonoscopy. In the first, the investigators re-screened 154 persons 
with initial negative colonoscopy at a mean of 66 months. None had cancer while 27% had 
at least one adenoma, only one of which was advanced. The presence of hyperplastic polyps 
in the baseline colonoscopy did not predict incident adenomas at re-screening. However, 
confounding factors including the use of non-steroidal anti-inflammatory agents might have 
reduced the rate of incident adenomas (Rex et al., 1996). The second study had a larger 
number of participants with negative initial colonoscopy (1256 persons, 56.7% of who were 
men). Again, baseline hyperplastic polyps did not predict incident advanced adenomas. At 
repeat colonoscopy, no participants had cancer and 16% had at least one adenoma. Only 
1.3% of participants had advanced adenomas, more than 50% of which were located in the 
distal colon. Men were more likely than women to have any adenoma, especially advanced 
adenoma (RR 1.88 and 3.31, respectively) (Imperiale et al., 2008).  
In 2006, two population-based studies confirmed that CRC risk following a negative 
colonoscopy remained low, for as long as 10-20 years. In a case-control study in the Rhine-
Neckar region of Germany, Brenner et al analyzed the records of 380 colonoscopy cases and 
485 controls without previous colonoscopy. They found a 74% risk reduction (OR 0.26 [95% 
CI, 0.16-0.40]) in subjects with negative colonoscopy compared to those without previous 
colonoscopy. This lower risk persisted even when the colonoscopy had been done up to 20 
years previously. Interestingly, risk was lower among subjects with multiple colonoscopies, 
who more often had a family history of CRC. On the other hand, with less than 20% of 
multiple-colonoscopy persons reporting previous polypectomy, the possibility of missed 
polyps on repeat colonoscopy would be very low indeed, thus contributing partly to this 
particular finding (Brenner et al., 2006). In addition, this study still demonstrated less CRC 
protection for the right colon compared to the left (OR 0.39 vs. 0.17, respectively), even when 
colonoscopies without documented completeness were excluded from analysis.  
Using Manitoba Health’s physician claims database, Singh et al retrospectively analyzed 
32,203 individuals with negative colonoscopy. They found that a negative colonoscopy was 
associated with 31% reduction in the CRC incidence up to 10 years (SIR of 0.66 at 1 year, 0.55 
at 5 years, and 0.28 at 10 years). The proportion of right-sided CRC (defined as cecum to 
hepatic flexure in this study) was significantly higher in the colonoscopy cohort compared 
to that in the provincial population (47% vs. 28%; P<0.001). Colorectal cancer cases were 
more likely to be right-sided if diagnosed within the initial 2 years, compared to those 
diagnosed more than 5 years, following the index colonoscopy. There was a non-significant 
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trend toward general practitioners performing the index colonoscopy cases with subsequent 
CRC detection (Singh et al., 2006).  
In yet another population-based retrospective analysis in Saarland, Germany, which 
examined a larger number of participants (533 with negative colonoscopy and 2701 without 
previous colonoscopy), Brenner et al arrived at similar conclusions. No cancer was detected 
in participants within an average of 11.9 years from negative baseline colonoscopy. The 
prevalence of advanced neoplasms was more than 60% reduced at 15 years, and 
approximately 50% reduced beyond 16 years, compared to those without colonoscopy 
(Brenner et al., 2010b). 
Certainly, a negative colonoscopy in and of itself is not a tool that can reduce CRC incidence 
as a colonoscopy with polypectomy can. Its inherent value exists in its ability to reliably 
predict the sustained low risk of CRC in the near and distant future. Consequently, a 
negative colonoscopy supports the lengthening of colonoscopic screening intervals up to 10 
years or longer, which in turn increases the cost-effectiveness of the CRC screening process 
in clinical practice.  
8. Gender and location in CRC protection by colonoscopy 
The weight of evidence suggests that overall, colonoscopy protects against the development 
of CRC. However, the degree of benefit apparently varies by colonic location and by gender. 
Studies by Brenner (Brenner et al., 2010a) and Singh (Singh et al., 2010a) demonstrated 
reduced incidence and mortality of distal, but not proximal CRC. Even in studies, which 
suggest protection against proximal CRC, that effect appears muted (Brenner et al., 2011).  
In addition, there are differences in the CRC incidence and protection by colonoscopy in 
men and women. In a large meta-analysis consisting of 17 studies involving 924,932 men 
and women, Nguyen et al provided strong evidence that men are at greater risk for 
advanced colorectal neoplasia across all age groups. The pooled relative risk for advanced 
neoplasia for men compared with women was 1.83 (95% CI, 1.69 -1.97) (Nguyen et al., 2009). 
Although men in general appear to be more likely to develop incident adenomas of all types 
(Imperiale et al., 2008), Schoenfeld and colleagues urged the use of the full colonoscopy in 
women for CRC screening in particular due to the increased prevalence of proximal 
advanced lesions in women (Schoenfeld et al., 2005).  
Why colonoscopy might not protect as well against proximal CRC is not well understood. The 
questions are: (1) Are more missed or early cancers located in the proximal colon? (2) Do 
cancers arise de novo or from missed or incompletely resected lesions following colonoscopy? 
(3) What patient or provider factors might contribute to this clinical observation? 
Pohl and Robertson found that a significant number of interval cancers came from missed 
lesions, which could be either cancer or adenomas. They estimated the adenoma prevalence in 
the screening cohort, adenoma miss rates, cancer prevalence among patients with adenomas 
based on size, and rates of adenoma-to-cancer transitions from the literature. They then used a 
model to apply these risk estimates to a hypothetical average-risk population that received 
screening colonoscopies. They found that the expected rate of persons with CRC from missed 
cancer and adenomas was 1.8 per 1000 persons within 5 years (range: 0.5-3.5 per 1000 screened 
persons) (Pohl & Robertson, 2010). This rate would more than double (5.1 per 1000 screened 
persons) if colonoscopy is applied to an entirely adenoma-bearing population. When this 
model was extrapolated to average-risk patient populations (Kahi et al., 2009; Lieberman et al., 
2007), they found that approximately 65% of the interval cancers might have been related to 
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missed adenomas. When compared against the observed risks in the adenoma-bearing 
populations (Alberts et al., 2000; Winawer et al., 1993, Pabby et al. 2005), between 70% and 80% 
of interval cancers might be attributed to a missed lesion. 
Bressler et al determined that the rates of missed cancer in the proximal colon were more 
than twice as high as those in the distal colon. Using the data from Ontario registries, they 
calculated the rates of interval colorectal cancers in different locations. The interval cancers 
were defined as cancers found within 6 and 36 months following a colonoscopy. The rates of 
the right-sided and transverse colon cancers were 5.9% and 5.5%, respectively, while those 
of the left-sided colon (distal to the splenic flexure) were halved (2.1%-2.3%) (Bressler et al., 
2007). The independent risk factors for these interval cancers were older age, diverticular 
disease, proximal CRC, colonoscopy in an office setting, and colonoscopy by an internist or 
family physician. 
Although women tend to have fewer adenomas than men, their adenomas tend to occur in 
the proximal colon. Therefore, it is not surprising to find that proximal CRC protection is 
lower in women than in men.  
Additional studies confirm that the issues of gender and CRC location are intertwined. 
Singh et al in a population-based study using the Manitoba Cancer Registry examined a 
cohort of 4883 patients with CRC. They classified 388 (7.9%) of these as early or missed 
cancers, i.e. those that were detected in the time frame of 6-36 months after a colonoscopy, 
with a range of 4.5% of distal cancers in men to 14.4% of proximal cancers (cecum to splenic 
flexure) in women (Singh et al., 2010b). In another case-control study in the California 
Medicaid population with 4458 CRC cases and 43,815 controls, Singh et al again found that 
despite the overall CRC risk reduction of 45% (RR 0.55 [95% CI, 0.46-0.65]), CRC protection 
for the left colon after negative colonoscopy (0.16) was disproportionately higher than that 
for the right side (0.67). The CRC risk reduction for both sexes was equivalent in the left 
colon (84%), but that for women in the right colon was only 18%, compared to 62% for men 
(Singh et al., 2007). 
Even in patients with negative colonoscopy, differential CRC protection by colonic location 
was also observed. In a large population-based retrospective analysis, Lakoff et al studied 
111,401 patients with negative previous colonoscopy. As in other studies on negative 
colonoscopy, they found a significant CRC risk reduction up to 14 years of follow-up, 
compared to the Ontario population (RR 0.21 [95%CI, 0.05-0.36]). However, the sustained 
reduction in incidence of proximal CRC only started in year 8 (Lakoff et al., 2008).  
9. Factors that influence the impact of video colonoscopy   
There are several possible explanations for missed or early CRC, particularly in the proximal 
colon. We can divide these into two categories, operator-independent and operator-
dependent. The operator-independent category includes tumor biology, patient-related 
factors and endoscopic technology. The operator-dependent category includes a set of key 
skills required for a successful colonoscopy performance, i.e., high adenoma detection rate 
and cecal intubation rate, adequate instrument withdrawal time and adequate training in 
both endoscopic techniques and conceptual knowledge of colon cancer. 
9.1 Operator-independent factors 
The traditional adenoma-to-carcinoma sequence characterized by chromosomal instability 
or mismatch repair defects explains most, but apparently not all, CRC. Recently, there is a 
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growing body of evidence pointing to other lesions as the precursors in CRC carcinogenesis 
(Jass, 2001). In 1990, Longacre and Fenoglio-Preiser first coined the term “serrated 
adenoma” as a distinct form of colonic neoplasia, 11% of which contained foci of 
intramucosal carcinoma (Longacre & Fenoglio-Preiser, 1990). Mäkinen et al showed that 
5.8% of all CRC in their study developed through the sessile serrated adenoma (SSA) 
pathway. These lesions have a predilection for the proximal colon (51% in the cecum) and 
excessive mucus production (Mäkinen et al., 2001). Sessile serrated adenomas in the 
proximal colon tend to be slightly larger, mucus-covered, flatter, and harder to detect than 
distal lesions (Spring et al., 2006; Torlakovic et al., 2003). Instead of  the progressive 
accumulation of APC, K-ras, DCC and p53 gene mutations in the traditional adenoma-to-
cancer sequence (Vogelstein et al., 1988), sessile serrated adenomas are characterized by the 
CpG island methylator phenotype (CIMP) and three-fold increase in DNA microsatellite 
instability (MSI) as a result of hypermethylation-related gene silencing and BRAF oncogene 
mutations (Mäkinen et al., 2001). This carcinogenic pathway may also be associated with 
more rapid transformation to cancer (Sawhney et al., 2006; Arain et al., 2008). Other studies 
also showed significantly higher MLH1 and MGMT promoter methylation in the normal 
proximal colon in older women (Worthley et al., 2010; Menigatti et al., 2009) and K-ras 
mutations in 80% of hyperplastic polyps in women, compared to 36% in men (Otori et al., 
1997), suggesting the intriguing possibility that the epigenetic signatures of cancers may 
have sex- and segment-specific, early-stage and normal-tissue counterparts.  
The failure to detect proximal lesions may also be caused by incomplete colonoscopy, which 
in turn is associated with patient-related factors such as prior history of pelvic or abdominal 
surgery (i.e., hysterectomy, gastrectomy), old age and inadequate bowel prep (Lee et al., 
2006). For the first two factors, adequate conscious sedation or water immersion technique 
has been used to improve the colonoscopy performance (Leung et al., 2010). For the third 
factor, poor colon preparation reduces polyp detection, both large and small, especially in 
the right colon (Froelich et al., 2005; Harewood et al., 2003). Split-prep protocol has been 
used to address this problem (Marmo et al., 2010).  
Another way of rendering the colonoscopy safe and painless is the use of computer-assisted 
self-propelled colonoscopes and swallowed video capsules for atraumatic locomotion 
through the colon. Several different systems have been tested for their feasibility. The 
Invendoscope™ (Invendo Medical, Kissing, Germany) is a single-use colonoscope based on 
motor driven inverted sleeve technology with a working channel (Rösch et al., 2008). This 
system has been shown to nearly painlessly achieve high cecal intubation rate comparable to 
that of the video colonoscope (Groth et al., 2011). However, no data are currently available 
on its diagnostic accuracy. The Endotics System (ES) is another robotic device composed of a 
workstation and a disposable probe, the advancing of which through the colon follows a 
cyclic sequence of steps (Cosentino et al., 2009). Although taking longer time to complete 
and having lower cecal intubation rate, the ES has been shown to have comparable 
sensitivity and specificity for the detection of lesions and require no sedation (Tumino et al., 
2010). The Aeroscope (GI View Ltd, Ramat Gan, Israel), a self-propelled, disposable 
endoscope using low-pressure carbon dioxide to propel a balloon device through the colon, 
on the other hand, did not reduce abdominal discomfort in healthy volunteers although it 
did achieve cecal intubation (Vucelic et al., 2006). The Video Capsule Endoscopy (Given 
Imaging Ltd., Yoqneam, Israel), a pill-size capsule activated upon swallowing, 
demonstrated lower sensitivity compared to that of standard colonoscopy (Van Gossum et 
al., 2009).    
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Regular white light technology may contribute to the under-recognition of the neoplastic 
lesions in the proximal colon. For paler, smaller, flatter adenomas, the use of high-definition 
white light and chromoendoscopy with methylene blue or indigo carmine has been shown 
to improve adenoma detection rate (Rex, 2010). Electronic highlighting such as narrow band 
imaging (NBI), Fuji Intelligent Chromo Endoscopy (FICE), autofluorescence and I-scan have 
not consistently proved effective to augment adenoma detection rate.  
Another method of increasing the rate of polyp detection is to improve the view through the 
colonoscopic lens. Wide-angle-view (> 170 degrees) colonoscopy, hooded colonoscopy and 
the Third-Eye Retroscope are several new technologies being developed to expose hidden 
mucosa during colonoscopy. They have shown some initial promise in improving adenoma 
detection and are under active investigation (Rex, 2010). 
9.2 Operator-dependent factors 
Colonoscopy performance is clearly operator-dependent requiring quality training and 
experience. Tandem endoscopic studies showed miss rates of 0-6% for adenomas 1 cm or 
larger, and 12-13% for adenomas 6-9 mm in size, and 15-27% for adenomas 5 mm or smaller 
(Rex et al., 1997; Hixson et al., 1990). When computed tomography colonography (CTC) was 
used in segmental unblinding to assess polyp detection during colonoscopy, the miss rates 
increased to 12% for adenomas 1 cm or larger (Pickhardt et al., 2004).  
These miss rates varied among endoscopists, suggesting that skillful colonoscopy 
performance plays a major role in neoplasia detection and prevention. In a large tandem 
endoscopic study, Chen et al demonstrated a wide range of adenoma miss rates from 17% to 
48% among 26 colonoscopists (Chen et al., 2007). Rex et al in another large study also 
showed cancer miss rates of 3% for gastroenterologists and 13% for non-gastroenterologists 
(Rex et al., 1997). Other studies also found that endoscopist quality measures were closely 
associated with post-colonoscopy or interval colorectal cancer. Colonoscopy by an internist 
or family physician in the office setting was associated with higher CRC incidence following 
colonoscopy (Baxter et al., 2011; Bressler et al., 2007). In patients with negative colonoscopy, 
those who had their procedures performed by a gastroenterologist were less likely to 
develop CRC (Rabeneck et al., 2010). Interestingly, there was no correlation between high 
colonoscopy volume and lower CRC incidence, suggesting that ongoing training and 
tracking of quality indicators for colonoscopy are crucial.  
The optimal measures for “high quality” colonoscopy are under debate. Three frequently 
discussed indicators are adenoma detection rate, cecal intubation rate or endoscopy 
completion rate, and instrument withdrawal rate. Using the database of the National 
Colorectal Cancer Screening Program in Poland from 2000 to 2004, Kaminski et al studied a 
large population of 45,026 subjects who underwent colon cancer screening by 186 
endoscopists. They suggested that the higher an adenoma detection rate (ADR) (in this case, 
20% or higher), the better CRC protection could be obtained from the screening colonoscopy 
(Kaminski et al., 2010). The investigators used an ADR of 20% or higher as the gold standard 
and this ADR is close to those recommended in the US guidelines (15% among women and 
25% among men) (Rex et al., 2002). They found that the relative risks of interval cancer 
following colonoscopy were 10-12 folds higher if the ADR was less than 20%. They also 
found that the rate of cecal intubation was not significantly associated with the risk of 
interval cancer.  
The need for high cecal intubation or colonoscopy completion rates (95% or higher for 
screening in healthy adults) is based on repeated observations that CRC protection by 
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colonoscopy is suboptimal in the proximal colon as discussed above. Documentation of 
cecal intubation has been encouraged as part of ongoing quality improvement program (Rex 
et al., 2006). However, evidence for a strong association between cecal intubation and 
reduction in proximal CRC incidence or mortality has yet to be demonstrated. 
Likewise, instrument withdrawal rate emerged as an important quality indicator when 
withdrawal time quicker than 6 minutes was shown to be associated with a lower rate of 
adenoma detection (Barclay et al., 2006). However, later, in another study, institution-wide 
policies to keep the colonoscopic withdrawal time within the recommended limits had no 
effect on polyp detection rate (Sawhney et al., 2008). 
10. Conclusion 
In summary, the emergence of colonoscopy as the preferred screening test for colorectal 
cancer by both the public and the medical profession coincides with the substantial decline 
in the incidence and mortality related to this disease. The impact of colonoscopy on CRC 
incidence can be seen in various patient populations, including the adenoma cohorts and 
average-risk cohorts, and this positive protection effect can be long-lasting in individuals 
with negative colonoscopy as well. However, colonoscopy is imperfect when it comes to 
CRC protection in the proximal colon, especially in women, although men are more likely to 
develop incident adenomas. This gender and location disparity can be caused by multiple 
factors including tumor biology, technological shortcomings, patient-related issues and 
endoscopist skill level. When colonoscopy fails, often it is due to inadequate lesion detection 
by the endoscopist. Therefore, the endoscopist can bring about the most significant positive 
impact on CRC prevention through continuous quality improvement programs. 
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